News
Epics Therapeutics raises €7.2M for its drug discovery program
EPICS Therapeutics is a newly created spin-off company of ULB dedicated to develop novel therapeutic solutions for cancer, based on the highly innovative field of RNA epigenetics. We are delighted to welcome them in our incubator. Discover the official press release here.
Read moreGEMS, a Telecom spin-off of ULB is looking for a Business Developer
GEMS, ULB spin-off under creation, specialized in solving indoor connectivity problems of cellular networks of the future, is looking for a Business Developer to support the definition of its business strategy. Interested ? Please check the job offering here.
Read more